| Characteristics | All |
| Number | 334 |
| Mean Age, years (SD) | 35.2 (10.5) |
| Female Sex | 304 (92%) |
| Race/Ethnicity | All |
| White | 256 (77%) |
| Latinx | 47 (16%) |
| Black-African American | 21 (7%) |
| Asian | 13 (4%) |
| Black-African |
12 (4%) |
| Other | 10 (4%) |
| Comorbidities | All |
| Obesity | 208 (63%) |
| Pulmonary disease | 101 (30%) |
| Tobacco smoking | 58 (17%) |
| Diabetes | 25 (7%) |
| CV disease | 8 (2%) |
| COVID-19 Medications | All |
| No treatment | 216 (65%) |
| Azithromycin | 46 (15%) |
| Corticosteroids | 42 (13%) |
| Oxygen supplementation | 25 (8%) |
| Anti-viral | 13 (3%) |
| Anti-malarial | 8 (2%) |
| IL-6 inhibitor | 1 (1%) |
| COVID-19 Complications | All |
| No serious events | 180 (54%) |
| HS flare | 110 (33%) |
| Shortness of breath | 49 (16%) |
| Sepsis | 4 (1%) |
| Death | 0 (0%) |
| COVID-19 Treatment Location | All |
| In hospital treatment | 24 (8%) |
| ED treatment | 45 (15%) |
| Home | 279 (84%) |